Home  |  Contact Us  |  NAV & Stock Price  |  Monthly Portfolio Summary

Ellsworth Fund Ltd. Announces Dividend, Earnings and Financial Update

FOR IMMEDIATE RELEASE
Morristown, NJ
April 16, 2007
Cusip 289074106
For Information:
Joshua P. Lake
(973) 631-1177

Ellsworth Fund Ltd. (AMEX - ECF) today reported financial highlights and certain portfolio information for the six months ended March 31, 2007.

The Fund declared its eighty-third quarterly dividend today:

Payable date

Record date

$0.08 per share
from ordinary income

indent.gif (819 bytes)indent.gif (819 bytes)

May 30, 2007

indent.gif (819 bytes)indent.gif (819 bytes)

May 16, 2007

  Three Months Ended
March 31
Six Months Ended
March 31
Earnings Report

2007

2006

2007

2006

Net Income

$1,163,000

$1,203,000

$2,229,000

$2,145,000

Per Share

$0.09

$0.10

$0.18

$0.17

Shares Outstanding

12,659,098

12,429,083

12,659,098

12,429,083

Total Net Assets $123,187,000 $118,207,000 $123,187,000 $118,207,000
Net Asset Value Per Share

$9.73

$9.51

$9.73

$9.51

 

Fund Statistics as of March 31, 2007 Top Ten Holdings by underlying common stock as of March 31, 2007
% of
Market price $8.58 Net Assets
Net asset value (NAV) $9.73 The Walt Disney Company 3.0
Premium/(Discount) (11.82)% Celanese Corp. 2.7
Total Net Assets $123,187,000 Nuveen Investments, Inc. 2.5
12-Month income distribution $0.35 Prudential Financial, Inc. 2.4
Yield on market price 4.08% Equinix, Inc. 2.3
Ratio of expenses 1.11%* Bristol-Myers Squibb Co. 2.1
Ratio of net income 3.69%* MetLife, Inc. 2.1
Portfolio Turnover 42.94% Alleghany Corp. 2.0
Shares outstanding 12,659,098 Teva Pharmaceutical Industries Ltd. 2.0
* Annualized U.S. Bancorp 2.0
Major Industry Exposure % of Portfolio Ratings from Moody's
as of March 31, 2007 Net Assets as of March 31, 2007
Pharmaceuticals 12.2 (From S&P when Moody's
is unavailable)
% of
Portfolio
Insurance 10.8 Aa 13
Semiconductors 10.7 A 18
Energy   7.8 Baa 20
Banking/Savings and Loan   6.9 Ba   7
Computer Hardware   5.6 B 16
Multi-Industry   5.6 <B   1
Aerospace and Defense   5.1 NR 21
Telecommunications   4.8 Common Stock 4
Chemicals   4.1
Asset Allocation % of
as of March 31, 2007 Net Assets
Convertible Bonds & Notes 62.0
Convertible Preferred Stock 10.9
Mandatory Convertibles 20.7
Common Stock   4.2
Other Assets   2.2

Data is unaudited and as of March 31, 2007. This selected information should be read in conjunction with the financial statements and notes included in the Company's Annual Report to Shareholders for the twelve months ended September 30, 2006.

Detailed portfolio information is available on our website (http://www.ellsworthfund.com). Contact us by e-mail at info@ellsworthfund.com or call us at (973) 631-1177.

Ellsworth is a diversified closed-end management investment company. Ellsworth's investment objective is to seek a high level of total return on its assets through a combination of current income and capital appreciation. It seeks to achieve this objective by investing primarily in convertible securities.

 


 

Home  |  Contact Us  |  NAV & Stock Price  |  Legal Notice

info@ellsworthfund.com